AlphaGrep UK Ltd’s HealthEquity HQY Stock Holding History

AlphaGrep UK Ltd’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,725	Closed	-$341K	–	854
2025 Q4	$341K	Buy	+3,725	New	+$357K	0.11%	360

Other funds holding HQY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AlphaGrep UK Ltd's HQY Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of HealthEquity (HQY) in Q1 2026, closing a stake of 3,725 shares — an estimated $341K sold.

AlphaGrep UK Ltd first reported a position in HQY in Q4 2025 and held it in 1 quarter. The position peaked at $341K in Q4 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

AlphaGrep UK Ltd reported no remaining HealthEquity position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 3,725 HealthEquity shares in Q1 2026, an estimated $341K.
AlphaGrep UK Ltd first reported a position in HealthEquity in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's HealthEquity position peaked at $341K in Q4 2025.
485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.